Altimmune, Inc. ( ALT) - Key Metrics
ALT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.27 | -$0.19 | -$0.19 |
| 2025Q3 | $0 | -$0.21 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.27 | -$0.24 | -$0.24 |
| 2025Q1 | $0 | -$0.26 | -$0.22 | -$0.22 |
ALT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.32 |
| 2025Q3 | ? | -4.43 |
| 2025Q2 | ? | -3.56 |
| 2025Q1 | ? | -4.82 |
ALT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -5.47% | ? |
| 2025Q4 | -5.35% | ? |
| 2025Q3 | -3.53% | ? |
| 2025Q2 | -6.23% | ? |
| 2025Q1 | -4.46% | ? |
ALT
Price: $2.62
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.92 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 680703
Ebitda: -31.4 millionMarket Capitalization: 253.3 million